TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. Our powerful ‘deep biology’ discovery engine maps human tissue Treg behavior to disease processes, allowing us to identify and characterize novel targets for therapeutic intervention. Leveraging this platform, we are building a broad portfolio of novel therapies that modulate the immune system to restore human tissue immune homeostasis. TRexBio is headquartered in South San Francisco, California.
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $85M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | SV Health ... | svhealthin... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 08.03.2022 | Series A | $26M | - | svhealthin... |
| 22.06.2021 | Series A | $59M | - | svhealthin... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 08.03.2022 | TRexBio Cl... | TrexBio, a South San Francisco... | USA | - | finsmes.co... |
| 08.03.2022 | TRexBio Co... | SOUTH SAN FRANCISCO, Calif., M... | - | - | svhealthin... |
| 22.06.2021 | TRexBio : ... | TRexBio, a discovery stage com... | - | - | marketscre... |
| 22.06.2021 | TRexBio Cl... | June 22, 2021 08:00 AM Eastern... | - | - | svhealthin... |